Patrick Chun
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 4
- Cancer Cells and Metastasis 3
- Cancer-related Molecular Pathways 2
-
- Immune cells in cancer 7
- Immune Cell Function and Interaction 2
- Co-authors
- Mary A. Davis (4 shared papers)Mukesh K. Nyati (4 shared papers)Theodore S. Lawrence (4 shared papers)Felix Y. Feng (4 shared papers)Sooryanarayana Varambally (3 shared papers)Carlos López (2 shared papers)Zev A. Wainberg (2 shared papers)Arul M. Chinnaiyan (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Blood (4 papers)Cancer Research (3 papers)Clinical Cancer Research (1 paper)Molecular Oncology (1 paper)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Patrick Chun
18 papers receiving 354 citations
Peers
Comparison fields: 5 of 47
- Oncology 243
- Otorhinolaryngology 22
- Hematology 47
- Immunology 73
- Pulmonary and Respiratory Medicine 101
Countries citing papers authored by Patrick Chun
This map shows the geographic impact of Patrick Chun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Chun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Chun more than expected).
Fields of papers citing papers by Patrick Chun
This network shows the impact of papers produced by Patrick Chun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Chun. The network helps show where Patrick Chun may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Chun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 67 | |
| 2 | 2006 | 64 | |
| 3 | 2019 | 49 | |
| 4 | 2007 | 41 | |
| 5 | 2014 | 34 | |
| 6 | 2006 | 25 | |
| 7 | 2014 | 20 | |
| 8 | 2013 | 18 | |
| 9 | Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy. | 2009 | 17 |
| 10 | 2021 | 6 | |
| 11 | 2017 | 5 | |
| 12 | 2010 | 4 | |
| 13 | 2020 | 3 | |
| 14 | 2021 | 3 | |
| 15 | 2020 | 2 | |
| 16 | 2020 | 2 | |
| 17 | 2015 | 2 | |
| 18 | 2021 | 1 | |
| 19 | 2021 | 1 |
About Patrick Chun
Patrick Chun is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology and Surgery, having authored 19 papers that have together received 364 indexed citations. Recurring topics across this work include Immune cells in cancer (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers), Cancer Cells and Metastasis (3 papers), Lung Cancer Treatments and Mutations (3 papers), Immune Cell Function and Interaction (2 papers), Head and Neck Cancer Studies (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Oncology (243 citations), Otorhinolaryngology (22 citations), Hematology (47 citations), Immunology (73 citations) and Pulmonary and Respiratory Medicine (101 citations). Patrick Chun has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Mary A. Davis, Mukesh K. Nyati, Theodore S. Lawrence, Felix Y. Feng, Sooryanarayana Varambally, Carlos López, Zev A. Wainberg, Arul M. Chinnaiyan, Scott A. Tomlins and X. Li. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Research, Clinical Cancer Research and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.